Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

IMAC logo
$0.04 +0.01 (+19.85%)
As of 06/2/2025

About IMAC Stock (NASDAQ:IMAC)

Key Stats

Today's Range
$0.04
$0.05
50-Day Range
$0.03
$0.07
52-Week Range
$0.75
$1.65
Volume
4,498 shs
Average Volume
708,132 shs
Market Capitalization
$1.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
See More Headlines

IMAC Stock Analysis - Frequently Asked Questions

IMAC's stock was trading at $1.27 at the beginning of the year. Since then, IMAC stock has decreased by 96.5% and is now trading at $0.0441.
View the best growth stocks for 2025 here
.

IMAC Holdings, Inc. (NASDAQ:IMAC) announced its earnings results on Thursday, April, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.03. IMAC had a negative net margin of 75.40% and a negative trailing twelve-month return on equity of 52.17%.

IMAC (IMAC) raised $4 million in an initial public offering (IPO) on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMAC investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), iBio (IBIO), VBI Vaccines (VBIV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Energy Transfer (ET).

Company Calendar

Last Earnings
4/14/2022
Today
6/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Specialty Outpatient Clinics
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.54 million
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$15.22 million
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
0.05

Miscellaneous

Free Float
23,837,000
Market Cap
$974,648.00
Optionable
Not Optionable
Beta
-0.88
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:IMAC) was last updated on 6/3/2025 by MarketBeat.com Staff
From Our Partners